Gilead
Senti Bio raises $105 million for its new programmable biology platform and cancer therapies
Senti Biosciences, a company developing cancer therapies using a new programmable biology platform, said it has raised $105 million in a new round of financing led by the venture arm of life sciences
FBI and DHS accuse Chinese hackers of targeting US COVID-19 research
In a rare joint public statement, the FBI and Homeland Security’s cybersecurity advisory unit CISA have accused top Chinese hackers of trying to steal U.S. research related to the coronavirus st
Hydroxychloroquine, chloroquine and other potential COVID-19 treatments explained
During two of this week’s White House briefings, President Trump referred specifically to two potential treatments that have been identified by medical researchers and clinicians, and that have
FDA testing coronavirus treatments, including chloroquine, plasma from recovered COVID-19 patients
U.S. Food and Drug Administration Commissioner Stephen Hahn addressed the ongoing work of the agency in terms of its work on potential treatments and vaccines for the COVID-19 coronavirus currently sp